期刊文献+

肿瘤相关粘蛋白MUC1及其mRNA与卵巢上皮性肿瘤关系的研究

Alterations of tumor-associated mucin MUC1、MUC1mRNA in human ovarian epithelial neoplasms
下载PDF
导出
摘要 目的 :初步探讨肿瘤相关粘蛋白MUC1基因及其蛋白与卵巢上皮性肿瘤的关系。方法 :采用原位杂交法和免疫组化ABC法 ,检测 6 5例卵巢上皮性肿瘤组织和 8例正常卵巢组织MUC1mRNA及其蛋白的表达。结果 :MUC1mRNA和MUC1阳性表达皆位于胞浆和胞膜 ,多呈灶状分布。MUC1mRNA和MUC1在卵巢癌中的检出率分别为 75 .6 % ,80 .0 % ,显著高于良性上皮性肿瘤的 4 0 % ,4 5 %和正常卵巢组织的 2 5 .0 % ,37.5 % (P <0 .0 0 5 )。二者高表达与卵巢癌的期别晚、组织分化差及淋巴结转移有关。结论 :MUC1作为新型肿瘤标志物 ,与卵巢癌的发生。 Objective:To explore the expression of tumor associated mucin MUC1,MUC1 mRNA in human ovarian epithelial neoplasms.Methods:Immunohistochemistry and in situ hybridization were used to determine the expressions of MUC1,MUC1mRNA in human ovarian epithelial carcinogenesis.Results:MUC1mRNA and MUC1 protein positive dark blue and brown yellow granules were mainly intracytoplasmic.The positive cells were chiefly distributed in focuses.The positive expression rate of MUC1mRNA and MUC1 protein in ovarian epithelial carcinoma were 75.6%,80%,significantly higher than that in benign (40%,45%) and normal ovarian tissues(25%,37.5%)(P<0.005).The two high expressions were significantly associated with higher vicious degree of ovarian carcinoma,poor differentiation,and lymph nodes metastasis.Conclusion:As a new tumor mark,the high expression of MUC1 is well related with the generation and development of ovarian carcinoma.
出处 《现代妇产科进展》 CSCD 2003年第5期370-372,共3页 Progress in Obstetrics and Gynecology
关键词 卵巢肿瘤 粘蛋白类 免疫组织化学 原位杂交 Ovarian neoplasms Mucins Immunohistochemistry In situ hybridization
  • 相关文献

参考文献13

  • 1萨姆布鲁克 弗里奇 等.分子克隆实验指南:第2版[M].北京:科学出版社,1992.464-467.
  • 2Werdelin O, Meldal M, Jensen T. Processing of glycans on glycoprotdn and glycopeptide antigens in antigen-presenting cells[J] .Proc Nail Acad Sci USA,2002,99:9611-9613.
  • 3Boman F, Buisine MP, Wacrenier A, et al. Mucin gene transcripts in benign andborderline mucinous tumours of the ovary: an in situ hybridization study[ J]. J Pathol, 2001,193: 339-344.
  • 4The MUC gene family: Their role in diagnosis and early detection of pancreatic cancer[J] .Mol Cancer,2003,2:9.
  • 5Taylor-Papadmitriou J, Burchell JM, Hunkett T. MUC1 and the immunobiology of cancer[ J]. J Mammary Glad Biol Neoplasia, 2002,7:209-221.
  • 6Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian [J] .J Clin Invest,2002,109:571-577.
  • 7Taylor-Papadimitriou J, Burchell J, Miles DW, et al. MUC1 and cancer[ J]. Biochim Biophys Acta, 1999,1455:301-313.
  • 8Henderikx P, Coolen-van Neer N, Jacobs A. A human immunoglobulin G1 antibody originating from an in vitro-selected Fab phage antibody binds avidly to tumor-associated MUC1 and is efficiently internalized [J].Am J Pathol,2002,160:1597-1608.
  • 9Ino Y,Gotoh M,Sakamoto M, et al. Dysadherin,a cancer-associated cell membrane glycoprotdn, down-regulates E-cadherin and promotes metastasis[J]. Proc Nail Acad Sci USA,2002,99: 365-370.
  • 10Feng H, Ghazizadeh M, Konisld H, et al. Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas [J] .Jpn J Clin Oncol,2002,32:525-529.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部